Steve Kwilas, Ph.D. - Publications

Affiliations: 
2009 Rush University, Chicago, IL, United States 
Area:
Microbiology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Huttner A, Agnandji ST, Engler O, Hooper JW, Kwilas S, Ricks K, Clements TL, Jonsdottir HR, Nakka SS, Rothenberger S, Kremsner P, Züst R, Medaglini D, Ottenhoff T, Harandi AM, et al. Antibody responses to rVSV-ZEBOV vaccination for Ebola virus disease across doses and continents: five-year durability. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 37661067 DOI: 10.1016/j.cmi.2023.08.026  0.459
2023 Paulsen GC, Frenck R, Tomashek KM, Alarcon RM, Hensel E, Lowe A, Brocato RL, Kwilas SA, Josleyn MD, Hooper JW. Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: a Randomized, Controlled Phase 1 Study. The Journal of Infectious Diseases. PMID 37380156 DOI: 10.1093/infdis/jiad235  0.329
2020 Dean CL, Hooper JW, Dye JM, Zak SE, Koepsell SA, Corash L, Benjamin RJ, Kwilas S, Bonds S, Winkler AM, Kraft CS. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States. Transfusion. PMID 32129478 DOI: 10.1111/Trf.15739  0.339
2019 Perley CC, Brocato RL, Kwilas SA, Daye S, Moreau A, Nichols DK, Wetzel KS, Shamblin J, Hooper JW. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses. Plos One. 14: e0216700. PMID 31075144 DOI: 10.1371/Journal.Pone.0216700  0.432
2017 Golden JW, Beitzel B, Ladner JT, Mucker EM, Kwilas SA, Palacios G, Hooper JW. An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection. Scientific Reports. 7: 4679. PMID 28680057 DOI: 10.1038/S41598-017-04889-X  0.464
2017 ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, et al. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 189: E819-E827. PMID 28630358 DOI: 10.1503/cmaj.170074  0.531
2016 Dye JM, Wu H, Hooper JW, Khurana S, Kuehne AI, Coyle EM, Ortiz RA, Fuentes S, Herbert AS, Golding H, Bakken RA, Brannan JM, Kwilas SA, Sullivan EJ, Luke TC, et al. Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle. Scientific Reports. 6: 24897. PMID 27109916 DOI: 10.1038/Srep24897  0.404
2016 Bengtsson KL, Song H, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu H, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R, Glenn G, et al. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine. PMID 26921779 DOI: 10.1016/j.vaccine.2016.02.033  0.308
2016 Golden JW, Maes P, Kwilas SA, Ballantyne J, Hooper JW. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever. Journal of Virology. 90: 3515-29. PMID 26792737 DOI: 10.1128/JVI.02969-15  0.369
2015 Willet M, Kurup D, Papaneri A, Wirblich C, Hooper JW, Kwilas SA, Keshwara R, Hudacek A, Beilfuss S, Rudolph G, Pommerening E, Vos A, Neubert A, Jahrling P, Blaney JE, et al. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. The Journal of Infectious Diseases. PMID 26063224 DOI: 10.1093/Infdis/Jiv251  0.368
2015 Grant-Klein RJ, Altamura LA, Badger CV, Bounds CE, Van Deusen NM, Kwilas SA, Vu HA, Warfield KL, Hooper JW, Hannaman D, Dupuy LC, Schmaljohn CS. Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges. Human Vaccines & Immunotherapeutics. 11: 1991-2004. PMID 25996997 DOI: 10.1080/21645515.2015.1039757  0.307
2015 Martins K, Carra JH, Cooper CL, Kwilas SA, Robinson CG, Shurtleff AC, Schokman RD, Kuehl KA, Wells JB, Steffens JT, van Tongeren SA, Hooper JW, Bavari S. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein. Viral Immunology. 28: 62-70. PMID 25514232 DOI: 10.1089/vim.2014.0071  0.452
2013 Garrison AR, Radoshitzky SR, Kota KP, Pegoraro G, Ruthel G, Kuhn JH, Altamura LA, Kwilas SA, Bavari S, Haucke V, Schmaljohn CS. Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology. 444: 45-54. PMID 23791227 DOI: 10.1016/J.Virol.2013.05.030  0.574
2009 Kwilas S, Liesman RM, Zhang L, Walsh E, Pickles RJ, Peeples ME. Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. Journal of Virology. 83: 10710-8. PMID 19656891 DOI: 10.1128/Jvi.00986-09  0.689
2009 Hasman H, Pachucki CT, Unal A, Nguyen D, Devlin T, Peeples ME, Kwilas SA. Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4. Journal of Medical Microbiology. 58: 408-13. PMID 19273634 DOI: 10.1099/Jmm.0.006098-0  0.651
Show low-probability matches.